Stock UniverseDerived research view · source repositories remain read-only

Compugen Ltd. (CGEN)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
21.56
Global Rank
3159
Market Cap
169.30M
Latest Close
2.10
RS Composite
-2.49% · G#1550

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-23.91%
3M
0.96%
6M
33.76%
1Y
22.81%
3Y
105.88%
5Y
-72.66%
10Y
-69.83%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 242.43K · 30-day average: 611.05K · Max drawdown over stored range: -97.28%

Research Snapshot

Relative Strength vs SPX

RS Composite-2.49%
20D RS-27.21%
60D RS-16.87%
120D RS24.25%
Global RS Rank1550 · 53.80% percentile
Watch+Speculative RS Rank994 · 52.60% percentile
Group ScopeWatch+Speculative
Primary RS Rank146 · 68.12% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank403 / 701
Primary Percentile42.65
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for CGEN.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue267.533.45927.86472.764
Revenue Growth (YoY)3800%200%25.0%346.12%-16.722%161.14%
Gross Profit1.945.326.52531.45519.934
Operating Income-31.496-35.074-35.374-12.992-14.891
Free Cash Flow-28.486-22.983-34.59-36.05849.48631.328
Free Cash Flow Per Share-0.358-0.273-0.4-0.4110.5530.3339335104569486
EPS (Diluted) GAAP-0.373131-0.409999-0.39-0.214005-0.16
EPS Growth
EPS Non-GAAP
Gross Margin97.0%88.667%87.0%94.011%71.54%87.2863%
Operating Margin-1574.8%-584.567%-471.653%-38.83%-53.442%43.0515%
Profit Margin-1484.9%-570.05%-449.253%-56.051%-51.073%48.5721%
Free Cash Flow Margin-1424.3%-383.05%-461.2%-107.768%177.598%43.0543%
Shares Outstanding (Diluted)79.591284.20486.555687.633389.52893.8151
Shares Change (YoY)25.071%5.796%2.793%1.245%2.162%4.789%

SEC Quarterly Fundamentals

No processed quarterly rows for CGEN.